GDF5 and breast carcinoma: The proangiogenic effect of GDF5 can be regulated by anti-TGF-ß peptides and anti-GDF5 antibodies and applied as potential therapeutic tools for TGF-ß/GDF5-dependent breast cancer angiogenesis [38].